CA Dreamin': Carbonic Anhydrase Inhibitors, Macrophages, and Pulmonary Hypertension.
作者信息
Shimoda Larissa A
机构信息
Division of Pulmonary and Critical Care MedicineJohns Hopkins School of MedicineBaltimore, Maryland.
出版信息
Am J Respir Cell Mol Biol. 2019 Oct;61(4):412-413. doi: 10.1165/rcmb.2019-0122ED.
Abstract
摘要
相似文献
1
CA Dreamin': Carbonic Anhydrase Inhibitors, Macrophages, and Pulmonary Hypertension.加州之梦：碳酸酐酶抑制剂、巨噬细胞与肺动脉高压
Am J Respir Cell Mol Biol. 2019 Oct;61(4):412-413. doi: 10.1165/rcmb.2019-0122ED.
2
Sensitivity of respiratory center to carbon dioxide in emphysema and cor pulmonale: effects of carbonic anhydrase inhibition.肺气肿和肺心病中呼吸中枢对二氧化碳的敏感性：碳酸酐酶抑制的影响。
Am Heart J. 1957 Sep;54(3):319-41. doi: 10.1016/0002-8703(57)90120-5.
3
[Acid-base equilibrium in arterial blood and cerebrospinal fluid in heart insufficiency and cor pulmonale and its control by carbonic anhydrase inhibition].[心力衰竭和肺心病时动脉血与脑脊液中的酸碱平衡及其碳酸酐酶抑制控制]
Klin Wochenschr. 1962 Dec 15;40:1233-45. doi: 10.1007/BF01484389.
4
Carbonic anhydrase inhibitors: a review on the progress of patent literature (2011-2016).碳酸酐酶抑制剂：专利文献进展综述（2011 - 2016年）
Expert Opin Ther Pat. 2016 Aug;26(8):947-56. doi: 10.1080/13543776.2016.1203904. Epub 2016 Jul 11.
5
Carbonic anhydrase enzymes for regulating mast cell hematopoiesis and type-2 inflammation: a patent evaluation (WO2017/058370).用于调节肥大细胞造血和 2 型炎症的碳酸酐酶酶：专利评估 (WO2017/058370)。
Expert Opin Ther Pat. 2018 Oct;28(10):741-743. doi: 10.1080/13543776.2018.1501472. Epub 2018 Jul 19.
6
Structural study of interaction between brinzolamide and dorzolamide inhibition of human carbonic anhydrases.研究布林佐胺和多佐胺与人碳酸酐酶相互作用的结构。
Bioorg Med Chem. 2013 Nov 15;21(22):7210-5. doi: 10.1016/j.bmc.2013.08.033. Epub 2013 Aug 28.
7
Carbonic anhydrase inhibitors: inhibition of cytosolic carbonic anhydrase isozymes II and VII with simple aromatic sulfonamides and some azo dyes.碳酸酐酶抑制剂：用简单芳香族磺酰胺和一些偶氮染料抑制胞质碳酸酐酶同工酶II和VII。
Chem Biol Drug Des. 2009 Aug;74(2):196-202. doi: 10.1111/j.1747-0285.2009.00842.x. Epub 2009 Jun 22.
8
New hydroxypyrimidinone-containing sulfonamides as carbonic anhydrase inhibitors also acting as MMP inhibitors.新型含羟嘧啶酮的磺酰胺类化合物作为碳酸酐酶抑制剂，同时也作为 MMP 抑制剂。
Bioorg Med Chem Lett. 2010 Jun 15;20(12):3623-7. doi: 10.1016/j.bmcl.2010.04.109. Epub 2010 Apr 28.
9
First evaluation of organotellurium derivatives as carbonic anhydrase I, II, IV, VII and IX inhibitors.有机碲化物衍生物作为碳酸酐酶 I、II、IV、VII 和 IX 抑制剂的首次评价。
Bioorg Chem. 2018 Feb;76:268-272. doi: 10.1016/j.bioorg.2017.12.010. Epub 2017 Dec 5.
10
A simplified micromethod for the determination of carbonic anhydrase and its inhibitors.一种用于测定碳酸酐酶及其抑制剂的简化微量方法。
J Pharmacol Exp Ther. 1960 Sep;130:26-9.
引用本文的文献
1
ApoE [-/-] CA1-overexpressing knock-in mice aggravated atherosclerosis by increasing M1 macrophages.载脂蛋白E基因敲除（ApoE [-/-]）且CA1过表达的基因敲入小鼠通过增加M1巨噬细胞而加重动脉粥样硬化。
Atheroscler Plus. 2025 Mar 27;60:6-19. doi: 10.1016/j.athplu.2025.03.003. eCollection 2025 Jun.
2
Update in Pulmonary Vascular Diseases and Right Ventricular Dysfunction 2019.2019年肺血管疾病与右心室功能障碍的进展
Am J Respir Crit Care Med. 2020 Jul 1;202(1):22-28. doi: 10.1164/rccm.202003-0576UP.
本文引用的文献
1
Carbonic Anhydrase Inhibition Ameliorates Inflammation and Experimental Pulmonary Hypertension.碳酸酐酶抑制减轻炎症和实验性肺动脉高压。
Am J Respir Cell Mol Biol. 2019 Oct;61(4):512-524. doi: 10.1165/rcmb.2018-0232OC.
2
Hallmarks of Pulmonary Hypertension: Mesenchymal and Inflammatory Cell Metabolic Reprogramming.肺动脉高压的特征：间充质和炎症细胞的代谢重编程。
Antioxid Redox Signal. 2018 Jan 20;28(3):230-250. doi: 10.1089/ars.2017.7217. Epub 2017 Aug 14.
3
Macrophage Regulation during Vascular Remodeling: Implications for Pulmonary Hypertension Therapy.血管重塑过程中的巨噬细胞调节：对肺动脉高压治疗的启示
Am J Respir Cell Mol Biol. 2017 May;56(5):556-558. doi: 10.1165/rcmb.2017-0033ED.
4
Challenges and opportunities in treating inflammation associated with pulmonary hypertension.治疗与肺动脉高压相关炎症的挑战与机遇。
Expert Rev Cardiovasc Ther. 2016 Aug;14(8):939-51. doi: 10.1080/14779072.2016.1180976. Epub 2016 May 4.
5
Contribution of metabolic reprogramming to macrophage plasticity and function.代谢重编程对巨噬细胞可塑性和功能的作用。
Semin Immunol. 2015 Aug;27(4):267-75. doi: 10.1016/j.smim.2015.09.001. Epub 2015 Oct 9.
6
Pharmacology of acute mountain sickness: old drugs and newer thinking.急性高原病的药理学：旧药与新思维
J Appl Physiol (1985). 2016 Jan 15;120(2):204-15. doi: 10.1152/japplphysiol.00443.2015. Epub 2015 Aug 20.
7
Pulmonary vasodilation by acetazolamide during hypoxia: impact of methyl-group substitutions and administration route in conscious, spontaneously breathing dogs.乙酰唑胺在低氧状态下对肺血管的舒张作用：甲基取代和给药途径对清醒、自主呼吸犬的影响
J Appl Physiol (1985). 2014 Apr 1;116(7):715-23. doi: 10.1152/japplphysiol.01235.2013. Epub 2014 Jan 30.
8
Acetazolamide and chronic hypoxia: effects on haemorheology and pulmonary haemodynamics.乙酰唑胺和慢性低氧：对血液流变学和肺血流动力学的影响。
Eur Respir J. 2012 Dec;40(6):1401-9. doi: 10.1183/09031936.00216011. Epub 2012 Apr 20.
9
Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension.早期巨噬细胞的募集和替代激活对于缺氧诱导的肺动脉高压的后期发展至关重要。
Circulation. 2011 May 10;123(18):1986-95. doi: 10.1161/CIRCULATIONAHA.110.978627. Epub 2011 Apr 25.
10
Generation of nitric oxide from nitrite by carbonic anhydrase: a possible link between metabolic activity and vasodilation.碳酸酐酶催化亚硝酸盐生成一氧化氮：代谢活性与血管舒张之间的可能联系。
Am J Physiol Heart Circ Physiol. 2009 Dec;297(6):H2068-74. doi: 10.1152/ajpheart.00525.2009. Epub 2009 Oct 9.
Zotero 插件